Practical synthesis of (S)-2-(4-fluorophenyl)-3-methylbutanoic acid, key building block for the calcium antagonist Mibefradil

Tetrahedron Asymmetry

Volumn 8, Issue 21, 1997, Pages 3617-3623

  Crameri, Yvo ^a   Foricher, Joseph ^a   Scalone, Michelangelo ^a   Schmid, Rudolf ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 FLUOROPHENYL) 3 METHYLBUTANOIC ACID; CALCIUM ANTAGONIST; MIBEFRADIL; PHOSPHINE DERIVATIVE; RUTHENIUM; UNCLASSIFIED DRUG;

ANGINA PECTORIS; ARTICLE; CHIRALITY; CRYSTALLIZATION; HYDROGENATION; HYPERTENSION; LIGAND BINDING; PRIORITY JOURNAL; RACEMIC MIXTURE;

EID: 0031566704     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-4166(97)00498-9     Document Type: Article

References (29)

1. 1. (a) Hengartner, U.; Ramuz, U. to F. Hoffmann-La Roche AG, EP 177'960 (10 October 1985).
2. (b) Branca, Q.; Jaunin, R.; Märki, H.P.; Marti, F.; Ramuz, H. to F. Hoffmann-La Roche AG, EP 268'148 (4 April 1987).
3. 2. Crameri, Y.; Foricher, J.; Hengartner, U.; Jenny, Ch.; Kienzle, F.; Ramuz, H.; Scalone, M.; Schlageter, M.; Schmid, R.; Wang, S. Chimia 1997, 51, 303.
4. 3. Mishra, S. K.; Hermsmeyer, K. Circ. Res. 1994, 75, 144.
5. 4. Miyakado, M.; Ohno, N.; Okuno, Y.; Hirano, M.; Fujimoto, K.; Yoshioka, H. Agr. Biol. Chem. 1975, 39, 267.
6. 5. (a) Hayashi, T.; Kawamura, N.; Ito, Y. J. Am. Chem. Soc. 1987, 109, 7876.
7. (b) Hayashi, T.; Kawamura, N.; Ito, Y. Tetrahedron Lett. 1988, 46, 5969.
8. 6. Takemoto, I.; Kawamura, N.; Kaminaka, H. Biosci. Biotech. Biochem. 1994, 58, 2071.
9. 7. Ohta, T.; Takaya, H.; Kitamura, M.; Nagai, K.; Noyori, R. J. Org. Chem. 1987, 52, 3174.
10. 8. Uemura, T.; Zhang, X.; Matsumura, K.; Sayo, N.; Kumobayashi, H.; Ohta, T.; Nozaki, K.; Takaya, H. J. Org. Chem. 1996, 61, 5510.
11. 9. Petrignani, N.; Yonashiro, M. Synthesis, 1982, 523 and references therein.
12. 10. Noyce, D. S.; Heller, R. A. J. Am. Chem. Soc. 1965, 87, 4325.
13. 11. Foricher, J.; Schmid, R., F. Hoffmann-La Roche AG, EP Appl. 97100843.8 (21 January 1997).
14. 12. (a) Blagoev, B.; Ivanov, D. Synthesis 1970, 615;
15. (b) Weston, A. W.; DeNet, R. W. J. Am. Chem. Soc. 1951, 73, 4221.
16. 13. (a) Ohta, T.; Takaya, H.; Noyori, R. Tetrahedron Lett. 1990, 49, 7189;
17. (b) Ashby, M. T.; Halpern, J. J. Am. Chem. Soc. 1991, 113, 589;
18. (c) Saburi, M.; Takeuchi, H.; Ogasawara, M.; Tsukahara, T.; Ishii, Y.; Ikariya, T.; Takahashi, T.; Uchida, Y. J. Organometal. Chem. 1992, 428, 155;
19. (c) Chan, A. S. C.; Chen, C. C.; Yang, T. K.; Huang, J. H.; Lin, Y. C. Inorg. Chim. Acta 1995, 234, 95.
20. 14. Kienzle, F.; Wang, S., F. Hoffmann-La Roche AG, unpublished results.
21. 15. The optical purification of Prophen drugs by crystallization of their sodium salts has been reported: Manimaran, T.; Stahly, G. Tetrahedron: Asymmetry 1993, 4, 1949.
22. 16. (a) Nakayama, I. Advances in Pesticide Sciences, Geissbühler, H. Ed., Pergamon Press, Oxford, 1978, part 2, p. 174 ff;
23. (b) Yoshioka, H. CHEMTECH 1985, 482.
24. 17. (a) Schmid, R.; Cereghetti, M.; Heiser, B.; Schönholzer, P.; Hansen, H.-J. Helv. Chim. Acta 1988, 71, 897;
25. (b) Schmid, R.; Foricher, J.; Cereghetti, M.; Schönholzer, P. Helv. Chim. Acta 1991, 74, 370;
26. (c) Cereghetti, M.; Arnold, W.; Broger, E. A.; Rageot, A. Tetrahedron Lett. 1996, 37, 5347;
27. (d) Schmid, R.; Broger, E. A.; Cereghetti, M.; Crameri, Y.; Foricher, J.; Lalonde, M.; Müller, R. K.; Scalone, M.; Schoettel, G.; Zutter, U. Pure & Appl. Chem. 1996, 68, 131.
28. 18. Heiser, B.; Broger, E. A.; Crameri, Y. Tetrahedron: Asymmetry 1991, 2, 51.
29. 19. Cekovic, Z.; Saicic, R. J. Serb. Chem. 1985, 50, 211.